Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP-1201 in ALI and ARDS
NCT00789685Phase 2Completed
- Sponsor
- Faron Pharmaceuticals
- Start
- Feb 2009
- Primary completion
- Sep 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in acute lung injury (ALI), acute respiratory distress syndrome (ARDS), sponsored by Faron Pharmaceuticals. Started Feb 2009; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT00789685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789685.